USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

PortfoliosPositionsRebalanceAnalyzeOptimize Suggest Industries

US Market Closed: Feb 9, 18:06 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ADMP and FLML...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Adamis Pharmaceuticl and

Flamel Technologies S.A.

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Adamis Pharmaceuticl and Flamel Technologies S.A. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.11

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	81.48%
Values	Daily Returns

Suggest

Adamis Pharmaceuticl

Profile

0.17

Intraday

One Month

^0.00

0.00%

ADMP

OTCBB

Adamis Pharmaceuticl

Day Low	0.16	Open	0.16
Market Cap	15.8M	Volume	491032
Sector	Healthcare	Last Close	0.17
Last Traded	2/9/2012	Year High	Not Applicable
EBITDA	-6.8M	Year Low	Not Applicable
Book Value	-0.022	EPS	-0.076
Day High	0.179	Industry	Drug Delivery
Current EPS	-0.076	This Year EPS	Not Applicable

Flamel Technologies S.A.

Profile

6.65

Intraday

One Month

^0.07

1.06%

FLML

NGM

Flamel Technologies S.A.

Day Low	6.575	Open	6.68
P/B Ratio	5.01	Market Cap	163.9M
Volume	79805	Sector	Healthcare
Last Close	6.58	Founded	Yes
Short Ratio	1.00	Last Traded	2/9/2012
Year High	7.35	Percent Change	1.06%
EBITDA	-1.4M	Year Low	3.61
Absolute Change	0.07	Time	Not Applicable
Book Value	1.313	EPS	-0.162
PEG Ratio	0.20	Employees	291
Day High	6.69	Industry	Drug Delivery
Target Price	12.00	Current EPS	-0.162
This Year EPS	-0.17	Next Year EPS	0.51
Next Year PE	12.90	Dividend	Not Applicable